4//SEC Filing
Adams Catherine Owen 4
Accession 0001415889-24-023975
CIK 0001070494other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 6:53 PM ET
Size
5.9 KB
Accession
0001415889-24-023975
Insider Transaction Report
Form 4
Owen Adams Catherine
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-23+353,261→ 353,261 totalExercise: $16.29Exp: 2034-09-22→ Common Stock (353,261 underlying)
Footnotes (2)
- [F1]The Stock Option has been granted pursuant to the Issuer's 2024 Inducement Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- [F2]25% of the shares subject to the Stock Option will vest and become exercisable on September 23, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001816838
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 6:53 PM ET
- Size
- 5.9 KB